Smoking, cancer, and Parkinson's disease.
作者信息
Golbe L I, Bernholc A A, Duvoisin R C
出版信息
Ann Neurol. 1987 May;21(5):513. doi: 10.1002/ana.410210524.
PMID:3592644
Abstract
摘要
相似文献
1
Smoking, cancer, and Parkinson's disease.
Ann Neurol. 1987 May;21(5):513. doi: 10.1002/ana.410210524.
2
Smoking, cancer, and Parkinson's disease.吸烟、癌症与帕金森病。
Ann Neurol. 1986 Jul;20(1):105-6. doi: 10.1002/ana.410200120.
3
[Hydroxylation of debrisoquin in Parkinson's disease].[帕金森病中去甲丙咪嗪的羟化作用]
Presse Med. 1990 May 19;19(20):947-9.
4
Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine.帕金森病的生态遗传学：异喹胍的4-羟化作用。
Lancet. 1985 Nov 30;2(8466):1213-6. doi: 10.1016/s0140-6736(85)90743-3.
5
[A survey of debrisoquin hydroxylation polymorphism].[异喹胍羟基化多态性的调查]
Orv Hetil. 1986 Sep 21;127(38):2299-301.
6
7
Liver enzyme abnormalities in Parkinson's disease.帕金森病中的肝脏酶异常。
Geriatrics. 1991 Aug;46 Suppl 1:60-3.
8
Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotype.
Clin Pharmacol Ther. 1987 Mar;41(3):314-9. doi: 10.1038/clpt.1987.33.
9
Debrisoquine metabolism in parkinsonian patients treated with antihistamine drugs.帕金森病患者使用抗组胺药治疗时的异喹胍代谢
Lancet. 1987 Aug 15;2(8555):386. doi: 10.1016/s0140-6736(87)92396-8.
10
Oxidative polymorphism of debrisoquine in Parkinson's disease.帕金森病中异喹胍的氧化多态性。
J Neurol Neurosurg Psychiatry. 1990 Apr;53(4):289-92. doi: 10.1136/jnnp.53.4.289.
Zotero 插件